KR20090088173A - Dihydrofuran derivatives and synthesis of them using gold-catalyst - Google Patents

Dihydrofuran derivatives and synthesis of them using gold-catalyst Download PDF

Info

Publication number
KR20090088173A
KR20090088173A KR1020080013564A KR20080013564A KR20090088173A KR 20090088173 A KR20090088173 A KR 20090088173A KR 1020080013564 A KR1020080013564 A KR 1020080013564A KR 20080013564 A KR20080013564 A KR 20080013564A KR 20090088173 A KR20090088173 A KR 20090088173A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
catalyst
dihydrofuran
aryl
Prior art date
Application number
KR1020080013564A
Other languages
Korean (ko)
Other versions
KR100941736B1 (en
Inventor
이필호
박찬수
Original Assignee
강원대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강원대학교산학협력단 filed Critical 강원대학교산학협력단
Priority to KR1020080013564A priority Critical patent/KR100941736B1/en
Publication of KR20090088173A publication Critical patent/KR20090088173A/en
Application granted granted Critical
Publication of KR100941736B1 publication Critical patent/KR100941736B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/48Silver or gold
    • B01J23/50Silver
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/48Silver or gold
    • B01J23/52Gold

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A dihydrofuran derivative is provided to improve yield of the dihydrofuran derivative through intramolecular cyclization of alenyl alcohol compound and use as a precursor in synthesis of medicine or perfume. A dihydrofuran derivative is denoted by the chemical formula 1. In the chemical formula 1, R is independently (C1-C7) alkyl group, A is hydrogen, (C1-C7)alkyl, (C3-C8)cycloalkyl, (C6-C20)aryl or (C6-C20)aryl(C1-C7)alkyl. The dihydrofuran derivative is a compound of the chemical formula 2 or 3. The dihydrofuran derivative of the chemical formula 1 is produced through intramolecular cyclization of homoalenyl alcohol compound.

Description

다이하이드로 퓨란 유도체와 금 촉매를 이용한 이의 합성{Dihydrofuran derivatives and synthesis of them using gold-catalyst}Dihydrofuran derivatives and synthesis of them using gold-catalyst}

본 발명은 다이하이드로퓨란(dihydrofuran) 유도체 및 이의 제조방법에 관한 것이다. 보다 상세하게는, 금(Au) 촉매를 이용하여 알렌일 알코올 화합물의 분자내 고리화 반응을 통해 선택적으로 다이하이드로퓨란(dihydrofuran) 유도체를 제조하는 방법에 관한 것이다.The present invention relates to a dihydrofuran derivative and a method for preparing the same. More specifically, the present invention relates to a method for selectively preparing a dihydrofuran derivative through an intramolecular cyclization reaction of an allenyl alcohol compound using a gold (Au) catalyst.

다이하이드로퓨란(dihydrofuran) 유도체는 천연물을 합성하는데 기본적인 골격을 이루고 있으며, 생물학적 활성을 가지고 있기 때문에 의약품이나 향수 또는 향신료 등을 만드는데 중요한 전구체로 사용되고 있다. 이러한 다이하이드로퓨란(dihydrofuran) 화합물의 합성법으로 과거에는 1,3-다이카보닐 화합물을 통해 합성하였고, 최근에는 전이금속 촉매인 팔라듐(Pd), 니켈(Ni), 구리(Cu), 또는 몰리브덴(Mo) 등을 이용하여 합성한 예도 보고되었다. 특히 위와 같은 전이금속 촉매를 이용한 다이하이드로퓨란(dihydrofuran) 유도체의 합성은 입체 선택성이나 자리 선택성이 뛰어난 장점을 가지고 있기 때문에 천연물 합성에 매우 중요하며, 수 많은 화학자들에 의해 연구되고 있다.Dihydrofuran derivatives form a basic skeleton for synthesizing natural products, and because they have biological activities, they are used as important precursors for making medicines, perfumes, spices, and the like. In the past, the dihydrofuran compound was synthesized through a 1,3-dicarbonyl compound, and recently, a transition metal catalyst, palladium (Pd), nickel (Ni), copper (Cu), or molybdenum ( An example of synthesis using Mo) was also reported. In particular, the synthesis of dihydrofuran derivatives using the transition metal catalyst as described above is very important for the synthesis of natural products because it has the advantages of excellent stereoselectivity or site selectivity, has been studied by many chemists.

최근에는 루이스 산으로 작용하여 불포화 탄소의 π-결합을 활성화 시켜 친핵체와의 반응을 통해 다양한 유기 화합물을 합성할 수 있다고 알려진 금(Au) 촉매를 이용한 다이하이드로퓨란(dihydrofuran) 화합물을 합성한 예도 보고되어 있으며, 많은 연구가 수행되고 있다(J. Org. Chem . 1984, 49, 3762; Angew . Chem . Int . Ed . Engl. 1980, 19, 461; Tetrahedron. 1987, 43, 3309; J. Org . Chem . 1990, 55, 2995; J. Am . Chem . Soc. 1995, 117, 12895; Chem . Eur . J. 1997, 3, 1170; J. Am . Chem . Soc. 1998, 120, 9720; J. Comb . Chem . 1999, 1, 181; J. Org. Chem . 2000, 65, 4198; J. Am . Chem . Soc. 2000, 122, 4992; Org . Lett . 2000, 2, 297; Org. Lett. 2001, 3, 2537; Org . Lett. 2001, 3, 2717; Org . Lett. 2002, 4, 289; Org . Lett . 2002, 4, 1387; J. Am . Chem . Soc. 2004, 126, 11164; Org . Lett. 2005, 7, 3367; J. Am . Chem . Soc. 2007, 129, 1046). 이와 같은 금(Au) 촉매는 다른 전이금속 촉매들에 비해 가격이 비싸다는 단점을 가지고 있지만, 다른 금속 촉매들에 비해 반응성이 뛰어나고, 극히 적은 촉매량을 사용하여도 반응이 진행된다는 장점을 가지고 있다.Recently, a dihydrofuran compound was synthesized using a gold (Au) catalyst, which is known to be able to synthesize various organic compounds through reaction with nucleophiles by acting as a Lewis acid to activate π-bonding of unsaturated carbon. And many studies have been conducted ( J. Org. Chem . 1984, 49 , 3762; Angew . Chem . Int . Ed . Engl . 1980, 19 , 461; Tetrahedron . 1987, 43 , 3309; J. Org . Chem 1990, 55, 2995;. . J. Am Chem Soc 1995, 117, 12895;... Chem Eur J. 1997, 3, 1170;. J. Am Chem Soc 1998, 120, 9720;... J. Comb Chem 1999, 1, 181; .. J. Org Chem 2000, 65, 4198;... J. Am Chem Soc 2000, 122, 4992;.. Org Lett 2000, 2, 297;... Org Lett. 2001, 3 , 2537; Org . Lett . 2001, 3 , 2717; Org . Lett . 2002, 4 , 289; Org . Lett . 2002, 4 , 1387 ; J. Am . Chem . Soc . 2004, 126 , 11164; Org . Lett . 2005, 7 , 3367; J. Am . Chem . Soc . 2007, 129 , 1046). Such a gold (Au) catalyst has the disadvantage of being expensive compared to other transition metal catalysts, but has the advantage of being more reactive than other metal catalysts, the reaction proceeds even using a very small amount of catalyst.

종래 문헌 중에서 N. Krause와 A. Hoffmann-Roder 등에 의해 연구된 논문(Org . Lett ., 2001, 3, 2537; Synthesis, 2002, 1759;Org . Biomol . Chem ., 2005, 3, 387-391)에는 하기 반응식에서와 같이 다이하이드로퓨란의 3-위치에 메틸 등 알킬이 치환된 화합물 및 이의 제조방법이 공지되어 있다.In the literature, N. Krause and A. Hoffmann-Roder et al . ( Org . Lett . , 2001, 3 , 2537; Synthesis , 2002, 1759; Org . Biomol . Chem . , 2005, 3 , 387-391) In the following schemes, a compound in which alkyl is substituted such as methyl at the 3-position of dihydrofuran and a method for preparing the same are known.

Figure 112008011182500-PAT00001
Figure 112008011182500-PAT00001

Figure 112008011182500-PAT00002
Figure 112008011182500-PAT00002

그러나 다이하이드로퓨란 유도체가 다양한 천연물 합성에 적용되기 위하여는 다양한 작용기를 가지는 물질의 개발이 필요한 실정이며, 이에 따라 본 발명에서는 다이하이드로퓨란의 3-위치에 에스테르기를 가지는 새로운 다이하이드로퓨란 유도체를 제공함으로써 천연물 및 생리활성 물질의 합성에 유용한 중간체를 제공하고자 한다.However, in order for the dihydrofuran derivative to be applied to synthesis of various natural products, it is necessary to develop a substance having various functional groups. Accordingly, the present invention provides a new dihydrofuran derivative having an ester group at the 3-position of dihydrofuran. It is intended to provide useful intermediates for the synthesis of natural and bioactive substances.

본 발명의 목적은 다이하이드로퓨란의 3-위치에 에스테르기를 가지는 새로운 다이하이드로퓨란 유도체를 제조함으로써 천연물 및 생리활성 물질의 합성에 유용한 중간체를 제공하는 데 있다.It is an object of the present invention to provide new intermediates useful for the synthesis of natural and bioactive substances by preparing new dihydrofuran derivatives having ester groups at the 3-position of dihydrofuran.

또한 본 발명은 금(Au) 촉매를 이용하여 에스테르기를 가지는 알렌일 알코올 화합물의 분자내 고리화 반응을 통해 3-위치에 에스테르기를 가지는 다이하이드로퓨란(dihydrofuran) 유도체를 제조하는 방법을 제공하는데 또 다른 목적이 있다.In another aspect, the present invention provides a method for producing a dihydrofuran derivative having an ester group in the 3-position through the intramolecular cyclization reaction of the allylyl alcohol compound having an ester group using a gold (Au) catalyst There is a purpose.

본 발명은 하기 화학식 1로 표시되는 다이하이드로퓨란(dihydro-furan) 유도체 및 이의 제조방법을 제공한다. The present invention provides a dihydrofuran derivative represented by the following Chemical Formula 1 and a preparation method thereof.

[화학식 1][Formula 1]

Figure 112008011182500-PAT00003
Figure 112008011182500-PAT00003

본 발명에 따른 상기 화학식 1의 다이하이드로퓨란 유도체 제조방법은 금(Au) 촉매 하에 하기 화학식 4로 표시되는 알렌일 알코올 화합물의 분자 내 고리화반응을 통하여 탄소-산소 결합을 유도하는 것을 특징으로 한다.Dihydrofuran derivative manufacturing method of the formula (1) according to the present invention is characterized by inducing a carbon-oxygen bond through the intramolecular cyclization reaction of the allylyl alcohol compound represented by the following formula (4) under a gold (Au) catalyst .

[화학식 4][Formula 4]

Figure 112008011182500-PAT00004
Figure 112008011182500-PAT00004

상기 화학식 1 및 화학식 4에서, R은 독립적으로 (C1~C7)알킬기로부터 선택되고; A는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고, 상기 A에서 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있으며; n은 1 내지 3의 정수이다.In Formula 1 and Formula 4, R is independently selected from a (C1-C7) alkyl group; A is hydrogen, or is selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl, in which A is alkyl, cyclo Alkyl, aryl or arylalkyl is a halogen element, nitro group, hydroxy group, (C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkylcarbonyl, (C1-C7) alkoxycarbonyl, and formyl group May be substituted with one or more substituents selected from (-CHO); n is an integer of 1-3.

이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명에 따른 하기 화학식 1의 다이하이드로퓨란(dihydrofuran) 유도체를 제공한다. It provides a dihydrofuran derivative of the formula (1) according to the present invention.

[화학식 1][Formula 1]

Figure 112008011182500-PAT00005
Figure 112008011182500-PAT00005

상기 화학식 1에서, R은 독립적으로 (C1~C7)알킬기로부터 선택되고; A는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고, 상기 A에서 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬 카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있으며; n은 1 내지 3의 정수이다. 상기 화학식 1에서 n이 2 또는 3일 경우 R은 서로 다를 수 있으며, R이 서로 다른 에스테르기를 갖는 화합물도 본 발명의 범위에 포함된다. In Formula 1, R is independently selected from (C1-C7) alkyl group; A is hydrogen, or is selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl, in which A is alkyl, cyclo Alkyl, aryl or arylalkyl is a halogen element, nitro group, hydroxy group, (C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkyl carbonyl, (C1-C7) alkoxycarbonyl, and formyl group May be substituted with one or more substituents selected from (-CHO); n is an integer of 1-3. In Formula 1, when n is 2 or 3, R may be different from each other, and a compound in which R has a different ester group is also included in the scope of the present invention.

상기 화학식 1의 다이하이드로퓨란 유도체는 보다 구체적으로 하기 화학식 2 및 하기 화학식 3의 다이하이드로퓨란 유도체로부터 선택된다. The dihydrofuran derivative of Chemical Formula 1 is more specifically selected from the dihydrofuran derivatives of Chemical Formula 2 and Chemical Formula 3 below.

[화학식 2][Formula 2]

Figure 112008011182500-PAT00006
Figure 112008011182500-PAT00006

[화학식 3][Formula 3]

Figure 112008011182500-PAT00007
Figure 112008011182500-PAT00007

[상기 화학식 2 및 화학식 3에서, R 및 R'은 독립적으로 (C1~C7)알킬기로부터 선택되고;[In Formula 2 and Formula 3, R and R 'are independently selected from (C1-C7) alkyl group;

화학식 2에서 B1는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고;B 1 in formula (2) is hydrogen or selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl;

화학식 3에서 B2는 (C1~C7)알킬렌, (C3~C8)시클로알킬렌, (C6~C20)아릴렌, 또는 (C6~C20)아릴(C1~C7)알킬렌으로부터 선택되며;B 2 in formula (3) is selected from (C1-C7) alkylene, (C3-C8) cycloalkylene, (C6-C20) arylene, or (C6-C20) aryl (C1-C7) alkylene;

상기 B1 및 B2의 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있다.]Alkyl, cycloalkyl, aryl or arylalkyl of B 1 and B 2 may be a halogen element, a nitro group, a hydroxy group, (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyl, (C 1 Or C1) alkoxycarbonyl, and one or more substituents selected from formyl groups (-CHO).]

상기 화학식 1 내지 화학식 3의 R 및 A, B1 및 B2에서 알킬은 직쇄상 또는 분쇄상 탄소사슬을 모두 포함하며, 상기 A, B1 및 B2에서 아릴은 페닐, 나프틸, 안트릴 등을 예로 들 수 있으며, 상기 A, B1 및 B2에서 아릴알킬은 상기 페닐, 나프틸, 안트릴 등의 아릴기가 치환된 (C1~C7)알킬을 예로 들 수 있다.Alkyl in R and A, B 1 and B 2 of Formulas 1 to 3 includes all linear or pulverized carbon chains, and aryl in A, B 1 and B 2 is phenyl, naphthyl, anthryl, etc. Examples of the arylalkyl in A, B 1 and B 2 include (C 1 -C 7) alkyl in which aryl groups such as phenyl, naphthyl and anthryl are substituted.

상기 화학식 1 내지 화학식 3의 A, B1 및 B2에 치환될 수 있는 치환기를 보다 구체적으로 예를 들면, 클로로, 요오도, 메틸, 메톡시. 니트로, 히드록시, 아세틸, 메톡시카보닐, 포밀 등이 있다.Substituents which may be substituted in A, B 1 and B 2 of Formulas 1 to 3 are more specifically, for example, chloro, iodo, methyl, methoxy. Nitro, hydroxy, acetyl, methoxycarbonyl, formyl and the like.

본 발명에 따른 상기 화학식 1의 다이하이드로퓨란 유도체는 보다 구체적으로 하기 구조의 화합물로부터 선택될 수 있다.The dihydrofuran derivative of Chemical Formula 1 according to the present invention may be more specifically selected from compounds having the following structure.

Figure 112008011182500-PAT00008
Figure 112008011182500-PAT00008

Figure 112008011182500-PAT00009
Figure 112008011182500-PAT00009

[상기 구조식에서 R 및 R'은 독립적으로 (C1~C7)알킬기로부터 선택된다.][Wherein R and R 'are independently selected from (C1-C7) alkyl groups.]

이하, 본 발명에 따른 다이하이드로퓨란 유도체의 제조방법에 대하여 상세히 설명한다.Hereinafter, a method for preparing a dihydrofuran derivative according to the present invention will be described in detail.

본 발명에 따른 다이하이드로퓨란(dihydrofuran) 유도체의 제조방법은 금(Au) 촉매 하에 하기 화학식 4로 표시되는 알렌일 알코올 화합물의 분자 내 고리화반응을 통하여 하기 화학식 1의 다이하이드로퓨란 유도체를 제조하는 것을 특징으로 한다.Method for preparing a dihydrofuran derivative according to the present invention is to prepare a dihydrofuran derivative of the general formula (1) through an intramolecular cyclization reaction of the allylyl alcohol compound represented by the following formula (4) under a gold (Au) catalyst It is characterized by.

[화학식 1][Formula 1]

Figure 112008011182500-PAT00010
Figure 112008011182500-PAT00010

[화학식 4][Formula 4]

Figure 112008011182500-PAT00011
Figure 112008011182500-PAT00011

[상기 화학식 1 및 화학식 4에서, R은 독립적으로 (C1~C7)알킬기로부터 선택되고; A는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고, 상기 A에서 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있으며; n은 1 내지 3의 정수이다.][In Formula 1 and Formula 4, R is independently selected from a (C1-C7) alkyl group; A is hydrogen, or is selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl, in which A is alkyl, cyclo Alkyl, aryl or arylalkyl is a halogen element, nitro group, hydroxy group, (C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkylcarbonyl, (C1-C7) alkoxycarbonyl, and formyl group May be substituted with one or more substituents selected from (-CHO); n is an integer of 1 to 3.]

상기 화학식 1 및 화학식 4에서 n이 2 또는 3인 경우에는 2 또는 3개의 알렌일 알코올기가 동시에 고리화반응이 일어날 수도 있고, 알렌일 알코올기를 생성한 후 고리화 반응하는 것을 단계적으로 진행할 수도 있다. 이를 화학식 3의 화합물을 예로 들면 하기 반응식 1과 같이 두 가지 반응과정으로 이루어질 수 있다.When n is 2 or 3 in Formulas 1 and 4, two or three allylyl alcohol groups may be cyclized at the same time, or a cyclization reaction may be performed step by step after generating the allenyl alcohol group. For example, the compound of Formula 3 may be composed of two reaction processes as in Scheme 1 below.

[반응식 1]Scheme 1

Figure 112008011182500-PAT00012
Figure 112008011182500-PAT00012

본 발명의 제조방법에서 사용되는 금(Au) 촉매는 1가 또는 3가의 할라이드계 금(Au)화합물을 사용하며, 1가의 금 촉매는 예를 들어 AuBr, AuCl, PPh3AuCl(Ph=phenyl) 등을 사용할 수 있고, 3가의 금 촉매는 AuBr3, AuCl3, 등을 사용할 수 있으며, PPh3AuCl를 촉매로 사용하는 것이 보다 바람직하다. The gold (Au) catalyst used in the preparation method of the present invention uses a monovalent or trivalent halide-based gold (Au) compound, and the monovalent gold catalyst is, for example, AuBr, AuCl, PPh 3 AuCl (Ph = phenyl) And the like. As the trivalent gold catalyst, AuBr 3 , AuCl 3 , and the like may be used, and PPh 3 AuCl is more preferably used as a catalyst.

본 발명의 제조방법에서는 상기 금(Au) 촉매 외에 은(Ag) 촉매를 병용하는 경우 금(Au) 촉매의 루이스 산도를 높임으로써 반응의 선택성 및 수율 측면에서 더욱 바람직하다. 상기 은(Ag) 촉매의 경우 AgOTf(OTf=trifluoromethane sulfonate), AgBF4, AgSbF6, AgAsF6, AgPF6로 이루어진 군에서 선택되는 것이 바람직하며, AgOTf를 촉매로 사용하는 것이 더욱 바람직하다.In the production method of the present invention, when the silver (Ag) catalyst is used in addition to the gold (Au) catalyst, the Lewis acidity of the gold (Au) catalyst is increased to further improve the selectivity and yield of the reaction. In the case of the silver (Ag) catalyst, AgOTf (OTf = trifluoromethane sulfonate), AgBF 4 , AgSbF 6 , AgAsF 6 , AgPF 6 is preferably selected from the group, and AgOTf is more preferably used as a catalyst.

본 발명의 제조방법에서 사용되는 은(Ag) 촉매는 AuBr3, AuCl3와 같이 3가의 금(Au) 촉매를 사용하는 경우 은(Ag) 촉매는 금(Au) 촉매에 대해 2 ~ 4몰(mole)배, 보다 좋게는 3몰배를 사용한다. 또한 AuBr, AuCl, PPh3AuCl와 같이 1가의 금(Au) 촉매의 경우 은(Ag) 촉매는 금(Au) 촉매에 대해 0.5 ~ 1.5몰(mole)배, 보다 좋게는 같은 촉매량을 사용하도록 한다. The silver (Ag) catalyst used in the preparation method of the present invention is a gold catalyst (Ag) when using a trivalent gold (Au) catalyst, such as AuBr 3 , AuCl 3 is 2 to 4 mol ( mole) times, more preferably 3 moles times. In the case of monovalent gold (Au) catalysts such as AuBr, AuCl, and PPh 3 AuCl, silver (Ag) catalysts should use 0.5 to 1.5 mole times, more preferably the same amount of catalyst, for gold (Au) catalysts. .

본 발명의 제조방법에서 사용되는 금(Au) 촉매의 사용량은 상기 화학식 4로 표시되는 알렌일 알코올 화합물에 대해 0.05 당량에서 0.1 당량 범위로 사용하도록 한다.The amount of the gold (Au) catalyst used in the preparation method of the present invention is to be used in the range of 0.05 equivalents to 0.1 equivalents to the allylyl alcohol compound represented by Formula 4.

본 발명의 제조방법에서 사용되는 반응 용매는 통상의 유기용매이며 아세토 나이트릴(acetonitrile), 디클로로메탄(dichloromethane), 다이클로로에탄(dichloroethane), 니트로메탄(nitromethane) 등으로부터 선택된 1종 또는 2종 이상의 혼합용매를 사용할 수 있다. 디클로로메탄(dichloromethane) 및 이를 포함한 혼합용매를 사용하는 것이 보다 바람직하다.The reaction solvent used in the production method of the present invention is a conventional organic solvent, one or two or more selected from acetonitrile, dichloromethane, dichloroethane, nitromethane, and the like. Mixed solvents can be used. It is more preferable to use dichloromethane and a mixed solvent including the same.

반응 온도는 상온에서 상기 반응을 수행하며, 바람직하기로는 15 내지 30도이고, 반응 시간은 반응물질, 용매의 종류 및 용매의 양에 따라 달라질 수 있으며, TLC 등을 통하여 출발물질은 호모알렌일 알코올 화합물이 모두 소모되었음을 확인 후 반응을 완결시키도록 한다. 반응이 완결되면 감압 하에서 용매를 증류시킨 후 관 크로마토그래피 등의 통상의 방법을 통하여 목적물을 분리 정제할 수 있다.The reaction temperature is carried out at room temperature, preferably 15 to 30 degrees, the reaction time may vary depending on the reactants, the type of solvent and the amount of the solvent, the starting material through the TLC homoalylyl alcohol Complete the reaction after confirming that all compounds have been consumed. When the reaction is completed, the solvent may be distilled off under reduced pressure, and then the target product may be separated and purified through a conventional method such as column chromatography.

본 발명에 따른 금(Au) 촉매를 이용한 알렌일 알코올 화합물의 분자 내 고리화 반응으로 인한 산소-탄소 결합방법을 통해 제조되는 다이하이드로퓨란(dihydrofuran) 유도체를 높은 수득률로 얻을 수 있다.Dihydrofuran derivatives prepared through the oxygen-carbon bonding method due to the intramolecular cyclization reaction of the allylyl alcohol compound using the gold (Au) catalyst according to the present invention can be obtained with high yield.

또한 이렇게 제조된 다이하이드로퓨란(dihydrofuran) 유도체는 천연물의 기본골격을 이루며 의약 또는 향수 등의 합성에 중요한 전구체로 이용될 수 있다.In addition, the dihydrofuran derivative thus prepared forms a basic skeleton of natural products and can be used as an important precursor for synthesis of medicine or perfume.

이하, 실시예를 통하여 본 발명의 구성을 보다 구체적으로 설명하지만, 하기의 실시예들은 본 발명에 대한 이해를 돕기 위한 것으로서, 본 발명의 범위가 여기 에 국한된 것은 아니다.Hereinafter, the configuration of the present invention in more detail through examples, the following examples are provided to help the understanding of the present invention, the scope of the present invention is not limited thereto.

[실시예 1] 3-에톡시카보닐-2,5-다이하이드로퓨란(3-ethoxycarbonyl-2,5-dihydrofuran)의 제조 Example 1 Preparation of 3-ethoxycarbonyl-2,5-dihydrofuran (3-ethoxycarbonyl-2,5-dihydrofuran)

질소 분위기 하에서 PPh3AuCl(7.4 mg, 0.015 mmol)와 AgOTf(3.9 mg, 0.015 mmol)를 CH2Cl2(0.5 ml)용매에 녹인 후 여기에 2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터(43 mg, 0.3 mmol)를 CH2Cl2(0.7 ml)용매에 녹여 실온에서 1시간 교반 시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관크로마토그래피로 분리하여 표제 화합물인 3-에톡시카보닐-2,5-다이하이드로퓨란(32 mg, 75 %)을 얻었다. 수득한 표제 화합물의 1H NMR (400 MHz, CDCl3 , 25℃, TMS) 데이터 값(d )은 표 1에 기재하였다.In a nitrogen atmosphere, PPh 3 AuCl (7.4 mg, 0.015 mmol) and AgOTf (3.9 mg, 0.015 mmol) were dissolved in a solvent of CH 2 Cl 2 (0.5 ml), and then 2-hydroxymethyl-buta-2,3-diene was added thereto. Ouck acid ethyl ester (43 mg, 0.3 mmol) was dissolved in a solvent of CH 2 Cl 2 (0.7 ml), stirred at room temperature for 1 hour, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 3-ethoxycarbonyl-2,5-dihydrofuran (32 mg, 75%). 1 H NMR (400 MHz, CDCl 3 , 25 ° C., TMS) data values ( d ) of the title compound obtained are listed in Table 1.

[실시예 2] 2-프로필-3-에톡시카보닐-2,5-다이하이드로퓨란(2-propyl-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 2 Preparation of 2-propyl-3-ethoxycarbonyl-2,5-dihydrofuran (2-propyl-3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-(1-히드록시부틸)-부타-2,3-디엔오익 엑시드 에틸 에스터(55 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(52 mg, 95 %)을 얻었다. Using 2- (1-hydroxybutyl) -buta-2,3-dienoic acid ethyl ester (55 mg, 0.3 mmol) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The title compound was obtained in the same manner as in Example 1 except that the title compound (52 mg, 95%) was obtained.

[실시예 3] 2-페네틸-3-에톡시카보닐-2,5-다이하이드로퓨란(2-phenethyl-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 3 Preparation of 2-phenethyl-3-ethoxycarbonyl-2,5-dihydrofuran (2-phenethyl-3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-(1-히드록시-3-페닐프로필)-부타-2,3-디엔오익 엑시드 에틸 에스터(74 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(61 mg, 83 %)을 얻었다.2- (1-hydroxy-3-phenylpropyl) -buta-2,3-dienoic acid ethyl ester (74 mg, 0.3 mmol) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The title compound (61 mg, 83%) was obtained in the same manner as in Example 1 except for using).

[실시예 4] 2-사이클로헥실-3-에톡시카보닐-2,5-다이하이드로퓨란(2-cyclohexyl-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 4 Preparation of 2-cyclohexyl-3-ethoxycarbonyl-2,5-dihydrofuran (2-cyclohexyl-3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-(시클로헥실히드록시메틸)-부타-2,3-디엔오익 엑시드 에틸 에스터(67 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(59 mg, 88 %)을 얻었다. Using 2- (cyclohexylhydroxymethyl) -buta-2,3-dienoic acid ethyl ester (67 mg, 0.3 mmol) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The title compound was obtained in the same manner as in Example 1, except that 59 mg (88%) of the title compound was obtained.

[실시예 5] 2-페닐-3-에톡시카보닐-2,5-다이하이드로퓨란(2-phenyl-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 5 Preparation of 2-phenyl-3-ethoxycarbonyl-2,5-dihydrofuran (2-phenyl-3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-(히드록시페닐메틸)-부타-2,3-디엔오익 엑시드 에틸 에스터(65 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(55 mg, 85 %)을 얻었다.The use of 2- (hydroxyphenylmethyl) -buta-2,3-dienoic acid ethyl ester (65 mg, 0.3 mmol) in place of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The same procedure as in Example 1 except for the title compound (55 mg, 85%).

[실시예 6] 2-(4-클로로페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-chlorophenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 6 Preparation of 2- (4-chlorophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-chlorophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[(4-클로로페닐)-히드록시메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(76 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(69 mg, 91 %)을 얻었다.2-[(4-chlorophenyl) -hydroxymethyl] -buta-2,3-dienoic acid ethyl ester (76 mg, 0.3) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester mmol) was used in the same manner as in Example 1 to obtain the title compound (69 mg, 91%).

[실시예 7] 2-(2-요오도페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(2-iodophenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 7 Preparation of 2- (2-iodophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (2-iodophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-2-(요오도페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(103 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(98 mg, 95 %)을 얻었다.2- [hydroxy-2- (iodophenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (103 mg instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester , 0.3 mmol) was used in the same manner as in Example 1 to obtain the title compound (98 mg, 95%).

[실시예 8] 2-(4-메틸페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-methylphenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 8 Preparation of 2- (4-methylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-methylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

질소 분위기 하에서 PPh3AuCl(13 mg, 0.03 mmol)와 AgOTf(8.0 mg, 0.03 mmol)를 CH2Cl2(0.5 ml)용매에 녹인 후 여기에 2-[히드록시-(4-메틸페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(70 mg, 0.3 mmol)를 CH2Cl2(0.7 ml)용매에 녹 여 실온에서 1시간 교반 시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관크로마토그래피로 분리하여 표제 화합물인 2-(4-메틸페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(62 mg, 88 %)을 얻었다. Under nitrogen atmosphere, PPh 3 AuCl (13 mg, 0.03 mmol) and AgOTf (8.0 mg, 0.03 mmol) were dissolved in a solvent of CH 2 Cl 2 (0.5 ml), and then 2- [hydroxy- (4-methylphenyl) -methyl ] -Buta-2,3-dieoic acid ethyl ester (70 mg, 0.3 mmol) was dissolved in a solvent of CH 2 Cl 2 (0.7 ml), stirred at room temperature for 1 hour, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 2- (4-methylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (62 mg, 88%).

[실시예 9] 2-(2,4,6-트라이메틸페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(2,4,6-trimethylphenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 9 2- (2,4,6-trimethylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (2,4,6-trimethylphenyl) -3-ethoxycarbonyl-2 , 5-dihydrofuran)

질소 분위기 하에서 PPh3AuCl (13 mg, 0.03 mmol)와 AgOTf (8.0 mg, 0.03 mmol)를 CH2Cl2 (0.5 ml)용매에 녹인 후 여기에 2-[히드록시-(2,4,6-트리메틸페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터 (78 mg, 0.3 mmol)를 CH2Cl2 (0.7 ml)용매에 녹여 실온에서 1시간 교반 시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관크로마토그래피로 분리하여 표제 화합물인 2-(2,4,6-트라이메틸페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란 (64 mg, 82 %)을 얻었다.Under nitrogen atmosphere, PPh 3 AuCl (13 mg, 0.03 mmol) and AgOTf (8.0 mg, 0.03 mmol) were added to CH 2 Cl 2 (0.5 ml) dissolved in a solvent, and then added 2- [hydroxy- (2,4,6-trimethylphenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (78 mg, 0.3 mmol) in CH 2 Cl 2 (0.7 ml) was dissolved in a solvent and stirred at room temperature for 1 hour to terminate the reaction. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 2- (2,4,6-trimethylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (64 mg, 82%). Got it.

[실시예 10] 2-(3-메톡시페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(3-methoxyphenyl)-3-ethoxycarbonyl-2,5-dihydro-furan)의 제조Example 10 2- (3-methoxyphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (3-methoxyphenyl) -3-ethoxycarbonyl-2,5-dihydro-furan) Manufacture

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-(3-메톡시페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(75 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(62 mg, 83 %)을 얻었다.2- [hydroxy- (3-methoxyphenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (75 mg) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester , 0.3 mmol) was obtained in the same manner as in Example 1 to obtain the title compound (62 mg, 83%).

[실시예 11] 2-(3-히드록시페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(3-hydroxyphenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 11 Preparation of 2- (3-hydroxyphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (3-hydroxyphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-(3-히드록시페닐)-메틸]-부타-2,3-디엔오익 에시드 에틸 에스터(70 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(18 mg, 26 %)을 얻었다.2- [hydroxy- (3-hydroxyphenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (70 mg) instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester , 0.3 mmol) was obtained in the same manner as in Example 1 to obtain the title compound (18 mg, 26%).

[실시예 12] 2-(4-니트로페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-nitrophenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 12 Preparation of 2- (4-nitrophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-nitrophenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-(4-니트로페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(79 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(71 mg, 90 %)을 얻었다. 2- [hydroxy- (4-nitrophenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (79 mg, instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester In the same manner as in Example 1 except for using 0.3 mmol), the title compound (71 mg, 90%) was obtained.

[실시예 13] 2-(4-포밀페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-formylphenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 13 Preparation of 2- (4-formylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-formylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[(4-포밀페닐)-히드록시메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(74 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(67 mg, 90 %) 을 얻었다.2-[(4-formylphenyl) -hydroxymethyl] -buta-2,3-dienoic acid ethyl ester (74 mg, 0.3 instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The title compound (67 mg, 90%) was obtained in the same manner as in Example 1 except that mmol) was used.

[실시예 14] 2-(4-아세틸페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-acetylphenyl)-3-ethoxycarbonyl-2,5-dihydrofuran)의 제조Example 14 Preparation of 2- (4-acetylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-acetylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran)

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-(4-아세틸페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(78 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(73 mg, 94 %)을 얻었다. 2- [hydroxy- (4-acetylphenyl) -methyl] -buta-2,3-dienoic acid ethyl ester (78 mg, instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester In the same manner as in Example 1 except for using 0.3 mmol), the title compound (73 mg, 94%) was obtained.

[실시예 15] 2-(4-메톡시카보닐페닐)-3-에톡시카보닐-2,5-다이하이드로퓨란(2-(4-methoxycarbonylphenyl)-3-ethoxycarbonyl-2,5-dihydro-furan)의 제조Example 15 2- (4-methoxycarbonylphenyl) -3-ethoxycarbonyl-2,5-dihydrofuran (2- (4-methoxycarbonylphenyl) -3-ethoxycarbonyl-2,5-dihydro- manufacture of furan

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[히드록시-(4-메톡시카보닐페닐)-메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터(83 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(81 mg, 97 %)을 얻었다.2- [hydroxy- (4-methoxycarbonylphenyl) -methyl] -buta-2,3-dienoic acid ethyl ester instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester 83 mg, 0.3 mmol) was used in the same manner as in Example 1 to obtain the title compound (81 mg, 97%).

[실시예 16] 1,4-(다이-3-에톡시카보닐-2,5-다이하이드로퓨란일)-벤젠, (1,4-(di-3-ethoxycarbonyl-2,5-dihydrofuranyl)-benzene)의 제조Example 16 1,4- (di-3-ethoxycarbonyl-2,5-dihydrofuranyl) -benzene, (1,4- (di-3-ethoxycarbonyl-2,5-dihydrofuranyl)- benzene)

질소분위기 하에서 인듐 (57.4 mg, 0.5 mmol), 염화리튬 (100 mg, 1.5 mmol)을 DMF (1 ml) 용매에 녹인 후 여기에 에틸 4-브로모부틴오에이트 (143 mg. 0.75 mmol)을 DMF (1.0 ml)에 녹인 후 실온에서 30분간 교반 시킨 후 티어프탈알데히드 (67 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 5 시간 교반시킨후 포화 탄산수소나트륨 수용액 (3 ml)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O (10 mL×3)로 추출하고 포화탄산수소나트륨 (10 ml)과 포화 염화나트륨 수용액 (10 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관크로마토그래피로 분리하여 표제화합물인 2-[(4-포밀페닐)-하이드록시메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터 (101 mg, 82 %)을 얻었다.In a nitrogen atmosphere, indium (57.4 mg, 0.5 mmol) and lithium chloride (100 mg, 1.5 mmol) were dissolved in a solvent of DMF (1 ml), and then ethyl 4-bromobutinate (143 mg. 0.75 mmol) was added to DMF ( 1.0 ml), stirred at room temperature for 30 minutes, then thiophthalaldehyde (67 mg, 0.5 mmol) was added to the reaction solvent, stirred at room temperature for 5 hours, and then saturated sodium hydrogencarbonate aqueous solution (3 ml) was added to terminate the reaction. I was. The mixture was extracted with Et 2 O (10 mL × 3) and washed with saturated sodium bicarbonate (10 ml) and saturated aqueous sodium chloride solution (10 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound 2-[(4-formylphenyl) -hydroxymethyl] -buta-2,3-dienoic acid ethyl ester (101 mg, 82%).

Figure 112008011182500-PAT00014
Figure 112008011182500-PAT00014

질소 분위기 하에서 PPh3AuCl(7.4 mg, 0.015 mmol)와 AgOTf(3.9 mg, 0.015 mmol)를 CH2Cl2(0.5 ml)용매에 녹인 후 여기에 2-[(4-포밀페닐)-하이드록시메틸]-부타-2,3-디엔오익 엑시드 에틸 에스터 (74 mg, 0.3 mmol)를 CH2Cl2(0.7 ml)용매에 녹 여 실온에서 1시간 교반 시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관크로마토그래피로 분리하여 표제 화합물인 2-(4-포밀페닐)-2,5-다이하이드로퓨란-3-카복실릭 엑시드 에틸 에스터(67 mg, 90 %)을 얻었다.Under nitrogen atmosphere, PPh 3 AuCl (7.4 mg, 0.015 mmol) and AgOTf (3.9 mg, 0.015 mmol) were dissolved in a solvent of CH 2 Cl 2 (0.5 ml), and then 2-[(4-formylphenyl) -hydroxymethyl ] -Buta-2,3-dieoic acid ethyl ester (74 mg, 0.3 mmol) was dissolved in a solvent of CH 2 Cl 2 (0.7 ml), stirred at room temperature for 1 hour, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 2- (4-formylphenyl) -2,5-dihydrofuran-3-carboxylic acid ethyl ester (67 mg, 90%).

Figure 112008011182500-PAT00015
Figure 112008011182500-PAT00015

질소분위기 하에서 인듐 (57.4 mg, 0.5 mmol), 염화리튬 (100 mg, 1.5 mmol)을 DMF (1 ml) 용매에 녹인 후 여기에 에틸 4-브로모부틴오에이트 (143 mg. 0.75 mmol)을 DMF (1.0 ml)에 녹인 후 실온에서 30분간 교반 시킨 후 3-(4-포밀페닐)-2,5-다이하이드로퓨란-2-카복실릭 엑시드 에틸 에스터 (123 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 18 시간 교반시킨후 포화 탄산수소나트륨 수용액 (3 ml)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O (10 mL×3)로 추출하고 포화탄산수소나트륨 (10 ml)과 포화 염화나트륨 수용액 (10 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관크로마토그래피로 분리하여 표제화합물인 3-[4-(2-에톡시카보닐-1-하이드록시-부타-2,3-디엔일)-페닐]-2,5-다이하이드로퓨란-2-카복실릭 엑시드 에틸 에스터 (116 mg, 65 %)을 얻었다.In a nitrogen atmosphere, indium (57.4 mg, 0.5 mmol) and lithium chloride (100 mg, 1.5 mmol) were dissolved in a solvent of DMF (1 ml), and then ethyl 4-bromobutinate (143 mg. 0.75 mmol) was added to DMF ( 1.0 ml), stirred at room temperature for 30 minutes, and then 3- (4-formylphenyl) -2,5-dihydrofuran-2-carboxylic acid ethyl ester (123 mg, 0.5 mmol) was added to the reaction solvent. After stirring for 18 hours at room temperature, saturated aqueous sodium hydrogen carbonate solution (3 ml) was added to terminate the reaction. The mixture was extracted with Et 2 O (10 mL × 3) and washed with saturated sodium bicarbonate (10 ml) and saturated aqueous sodium chloride solution (10 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound, 3- [4- (2-ethoxycarbonyl-1-hydroxy-buta-2,3-dienyl) -phenyl] -2,5-dihydro. Furan-2-carboxylic acid ethyl ester (116 mg, 65%) was obtained.

Figure 112008011182500-PAT00016
Figure 112008011182500-PAT00016

2-히드록시메틸-부타-2,3-디엔오익 엑시드 에틸에스터 대신에 2-[4-(2-에톡시카보닐-1-하이드록시부타-2,3-엔일)-페닐]-2,5-다이하이드로퓨란-3-카복실릭 엑시드 에틸 에스터(108 mg, 0.3 mmol)를 사용하는 것을 제외하고는 실시예 1과 동일하게 진행하여 표제 화합물(87 mg, 81 %)을 얻었다.2- [4- (2-ethoxycarbonyl-1-hydroxybuta-2,3-enyl) -phenyl] -2, instead of 2-hydroxymethyl-buta-2,3-dienoic acid ethyl ester The title compound (87 mg, 81%) was obtained in the same manner as in Example 1 except using 5-dihydrofuran-3-carboxylic acid ethyl ester (108 mg, 0.3 mmol).

[표 1] 실시예 화합물의 1H NMR 데이터TABLE 1 1 H NMR data of Example Compound

Figure 112008011182500-PAT00017
Figure 112008011182500-PAT00017

Figure 112008011182500-PAT00018
Figure 112008011182500-PAT00018

Figure 112008011182500-PAT00019
Figure 112008011182500-PAT00019

Claims (8)

하기 화학식 1로 표시되는 다이하이드로퓨란(dihydrofuran) 유도체:Dihydrofuran derivative represented by the following formula (1): [화학식 1][Formula 1]
Figure 112008011182500-PAT00020
Figure 112008011182500-PAT00020
[상기 화학식 1에서, R은 독립적으로 (C1~C7)알킬기로부터 선택되고; A는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고, 상기 A에서 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있으며; n은 1 내지 3의 정수이다.][In Formula 1, R is independently selected from a (C1-C7) alkyl group; A is hydrogen, or is selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl, in which A is alkyl, cyclo Alkyl, aryl or arylalkyl is a halogen element, nitro group, hydroxy group, (C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkylcarbonyl, (C1-C7) alkoxycarbonyl, and formyl group May be substituted with one or more substituents selected from (-CHO); n is an integer of 1 to 3.]
제 1 항에 있어서, The method of claim 1, 다이하이드로퓨란(dihydrofuran) 유도체는 하기 화학식 2 또는 화학식 3의 화합물로부터 선택되는 것을 특징으로 하는 다이하이드로퓨란(dihydrofuran) 유도체:Dihydrofuran derivative is a dihydrofuran derivative characterized in that it is selected from a compound of formula (2) or (3): [화학식 2][Formula 2]
Figure 112008011182500-PAT00021
Figure 112008011182500-PAT00021
[화학식 3][Formula 3]
Figure 112008011182500-PAT00022
Figure 112008011182500-PAT00022
[상기 화학식 2 및 화학식 3에서, R 및 R'은 독립적으로 (C1~C7)알킬기로부터 선택되고;[In Formula 2 and Formula 3, R and R 'are independently selected from (C1-C7) alkyl group; 화학식 2에서 B1는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고;B 1 in formula (2) is hydrogen or selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl; 화학식 3에서 B2는 (C1~C7)알킬렌, (C3~C8)시클로알킬렌, (C6~C20)아릴렌, 또는 (C6~C20)아릴(C1~C7)알킬렌으로부터 선택되며;B 2 in formula (3) is selected from (C1-C7) alkylene, (C3-C8) cycloalkylene, (C6-C20) arylene, or (C6-C20) aryl (C1-C7) alkylene; 상기 B1 및 B2의 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있다.] Alkyl, cycloalkyl, aryl or arylalkyl of B 1 and B 2 may be a halogen element, a nitro group, a hydroxy group, (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyl, (C 1 Or C1) alkoxycarbonyl, and one or more substituents selected from formyl groups (-CHO).]
제 2 항에 있어서, The method of claim 2, 다이하이드로퓨란(dihydrofuran) 유도체는 하기 구조의 화합물로부터 선택되는 것을 특징으로 하는 다이하이드로퓨란(dihydrofuran) 유도체:Dihydrofuran derivatives are selected from compounds of the structure:
Figure 112008011182500-PAT00023
Figure 112008011182500-PAT00023
[상기 구조식에서 R 및 R'은 독립적으로 (C1~C7)알킬기로부터 선택된다.][Wherein R and R 'are independently selected from (C1-C7) alkyl groups.]
금(Au) 촉매 하에 하기 화학식 4로 표시되는 호모알렌일 알코올 화합물의 분 자 내 고리화반응을 통하여 하기 화학식 1의 다이하이드로퓨란 유도체를 제조하는 것을 특징으로 하는 다이하이드로퓨란(dihydrofuran) 유도체의 제조방법.Preparation of a dihydrofuran derivative comprising preparing a dihydrofuran derivative of the general formula (1) through an intramolecular cyclization reaction of a homoalenyl alcohol compound represented by the following general formula (4) under a gold (Au) catalyst Way. [화학식 1][Formula 1]
Figure 112008011182500-PAT00024
Figure 112008011182500-PAT00024
[화학식 4][Formula 4]
Figure 112008011182500-PAT00025
Figure 112008011182500-PAT00025
[상기 화학식 1 및 화학식 4에서, R은 독립적으로 (C1~C7)알킬기로부터 선택되고; A는 수소이거나, (C1~C7)알킬, (C3~C8)시클로알킬, (C6~C20)아릴, 또는 (C6~C20)아릴(C1~C7)알킬로부터 선택되고, 상기 A에서 알킬, 시클로알킬, 아릴 또는 아릴알킬은 할로겐원소, 니트로기, 히드록시기, (C1~C7)알킬, (C1~C7)알콕시, (C1~C7)알킬카보닐, (C1~C7)알콕시카보닐, 및 포밀기(-CHO)로부터 선택되는 1종 이상의 치환기로 치환될 수 있으며; n은 1 내지 3의 정수이다.][In Formula 1 and Formula 4, R is independently selected from a (C1-C7) alkyl group; A is hydrogen, or is selected from (C 1 -C 7) alkyl, (C 3 -C 8) cycloalkyl, (C 6 -C 20) aryl, or (C 6 -C 20) aryl (C 1 -C 7) alkyl, in which A is alkyl, cyclo Alkyl, aryl or arylalkyl is a halogen element, nitro group, hydroxy group, (C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkylcarbonyl, (C1-C7) alkoxycarbonyl, and formyl group May be substituted with one or more substituents selected from (-CHO); n is an integer of 1 to 3.]
제 4 항에 있어서,The method of claim 4, wherein 상기 금(Au) 촉매는 1가의 금 촉매로서 AuBr, AuCl 또는 PPh3AuCl로부터 선택되거나, 3가의 금촉매로서 AuBr3, 또는 AuCl3로부터 선택되는 것을 특징으로 하는 다이하이드로퓨란 유도체의 제조방법. The gold (Au) catalyst is selected from AuBr, AuCl or PPh 3 AuCl as a monovalent gold catalyst, AuBr 3 or AuCl 3 as a trivalent gold catalyst, a method for producing a derivative. 제 5 항에 있어서, The method of claim 5, wherein 상기 금(Au) 촉매 외에 AgOTf, AgBF4, AgSbF6, AgAsF6, 및 AgPF6로 이루어진 군에서 선택되는 은(Ag) 촉매를 병용하는 것을 특징으로 하는 다이하이드로퓨란 유도체의 제조방법.A method for producing a dihydrofuran derivative, characterized by using a silver (Ag) catalyst selected from the group consisting of AgOTf, AgBF 4 , AgSbF 6 , AgAsF 6 , and AgPF 6 in addition to the gold (Au) catalyst. 제 6 항에 있어서, The method of claim 6, 상기 은 촉매의 사용량은 3가의 금(Au) 촉매를 사용하는 경우 금(Au) 촉매에 대해 2 내지 4 몰배이고, 1가의 금(Au) 촉매를 사용하는 경우 0.5 내지 1.5몰배인 것을 특징으로 하는 다이하이드로퓨란 유도체의 제조방법.The use amount of the silver catalyst is 2 to 4 mole times with respect to the gold (Au) catalyst when using a trivalent gold (Au) catalyst, 0.5 to 1.5 mole times when using a monovalent gold (Au) catalyst, characterized in that Method for preparing a dihydrofuran derivative. 제 4 항에 있어서, The method of claim 4, wherein 상기 고리화반응은 아세토나이트릴(acetonitrile), 디클로로메탄(dichloromethane), 디클로로에탄(dichloroethane), 니트로메탄(nitromethane) 디클로로메탄(CH2Cl2) 및 이들의 혼합용매로부터 선택되는 용매 하에서 수행하는 것 을 특징으로 하는 다이하이드로퓨란 유도체의 제조방법.The cyclization reaction is carried out under a solvent selected from acetonitrile, dichloromethane, dichloroethane, nitromethane dichloromethane (CH 2 Cl 2 ), and a mixed solvent thereof. Method for producing a dihydrofuran derivative, characterized in that.
KR1020080013564A 2008-02-14 2008-02-14 Dihydrofuran derivatives and synthesis of them using gold-catalyst KR100941736B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080013564A KR100941736B1 (en) 2008-02-14 2008-02-14 Dihydrofuran derivatives and synthesis of them using gold-catalyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080013564A KR100941736B1 (en) 2008-02-14 2008-02-14 Dihydrofuran derivatives and synthesis of them using gold-catalyst

Publications (2)

Publication Number Publication Date
KR20090088173A true KR20090088173A (en) 2009-08-19
KR100941736B1 KR100941736B1 (en) 2010-02-11

Family

ID=41206936

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080013564A KR100941736B1 (en) 2008-02-14 2008-02-14 Dihydrofuran derivatives and synthesis of them using gold-catalyst

Country Status (1)

Country Link
KR (1) KR100941736B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101029091B1 (en) 2010-04-08 2011-04-13 강원대학교산학협력단 Preparation method of dihydrofuran derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116982A (en) * 1976-07-27 1978-09-26 Basf Aktiengesellschaft 3-oximino-4-oxo-2,5-dimethyl-tetrahydrofuran
US4636571A (en) * 1983-06-13 1987-01-13 National Distillers And Chemical Corporation 4-carbalkoxy-2-ethyl-2,3-dihydrofurans

Also Published As

Publication number Publication date
KR100941736B1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
EP2931708B1 (en) Cyclopropylboronic compounds, method for preparing same and use thereof
Sato et al. Synthesis of Biaryls via Palladium‐Catalyzed [2+ 2+ 2] Cocyclization of Arynes and Diynes: Application to the Synthesis of Arylnaphthalene Lignans
Wang et al. Oxidative N-heterocyclic carbene-catalyzed [3+ 3] annulation reaction of enals with benzofuran-3-ones: Efficient access to benzofuran-fused δ-lactones
KR100941736B1 (en) Dihydrofuran derivatives and synthesis of them using gold-catalyst
CN101560191A (en) Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
WO2012085474A1 (en) Process for preparing chiral amino acids
CN111170926B (en) Method for catalyzing asymmetric synthesis of chiral beta-alkynyl-beta-aminoketone derivative
Shen et al. Highly enantioselective hydrogenation of exocyclic double bond of N-tosyloxazolidinones catalyzed by a neutral rhodium complex and its synthetic applications
JPWO2005085204A1 (en) Method for producing nitrogen-containing 5-membered ring compound
Solas et al. Synthesis of 4‐Furan‐and 4‐Pyrrol‐3‐yl‐2H‐chromenes from Naturally‐occurring Compounds by Gold (I)‐Catalyed Domino Reactions
CN108299198B (en) Preparation method of 1, 4-diketone compound
CN108285415B (en) Preparation method of 1, 5-diketone compound
KR101029091B1 (en) Preparation method of dihydrofuran derivatives
KR101140134B1 (en) Novel 3-arylbutenolide derivatives and its preparation method
KR100696187B1 (en) Preparation method of 2-2-aminoethyl-1-methylpyrrolidine
Castro et al. An oxepinone route to carbohydrate based oxepines
US6872840B1 (en) Synthesis of 8-membered carbocyclic compound having diexomethylene groups
JP2015172024A (en) Chiral bicyclic diene ligand having hydrogen bond formation amide group
KR20010092864A (en) Optically active cyanobutantriol derivatives and process for preparing same
KR100941173B1 (en) Dihydrofuran derivatives, and process for preparing them using Au catalyst
KR101220148B1 (en) Novel pyrazole derivatives and its preparation method
KR101400989B1 (en) Enantioselective manufacturing method of methyl 2-(1-hydroxy)-buta-2,3-dienolate derivatives and method for preparing sylvone using the same
KR100941174B1 (en) Furan derivatives, and process for preparing them using Ag catalyst
CN108863751B (en) Synthetic method of Z-type halogenated chalcone compound
JP4759722B2 (en) Process for producing aromatic carboxylic acid ester having a substituent

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20131205

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150109

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee